Several biotech companies, including Curie Bio and Biotech accelerator, have raised significant funds to support founders in developing therapeutics and reaching meaningful clinical data. Curie Bio closed a $380M pro rata Series A fund to aid portfolio companies.
Exclusive: Biotech accelerator https://t.co/zsfJTwVYom has raised $380 million for a new fund that will largely be invested in other biotechs that go through the accelerator and go on to raise a Series A round. https://t.co/DkfR1VLpDD
🚨 INNOVATORS TAKE NOTE! A fresh $380M to support early stage biotech. https://t.co/RZRYPehfaF Raises $380M Pro Rata Series A Fund To Support Portfolio Companies Through Clinical Trials https://t.co/Ytw6vsV3AR https://t.co/O9BlFCbviA
We've now raised almost $1b at https://t.co/6RqTolbiXy to provide therapeutics founders with the world’s best people and to fund their companies from the idea stage to meaningful clinical data. Our team has grown just a bit too. https://t.co/AlsiIF1BY0 https://t.co/fdlzcHucd0
We've now raised almost $1b at https://t.co/6RqTolbiXy to to provide therapeutics founders with the world’s best people and to fund their companies from the idea stage to meaningful clinical data. Our team has grown just a bit too. https://t.co/vab2GyCPk2 https://t.co/fdlzcHucd0
Exciting day for the team at @curie_bio - expanding its reach supporting biotech founders beyond seed financing and closing a $380M pro rata Series A fund to help drive portfolio companies to meaningful clinical data. #freethefounders https://t.co/jpJbNpbDkU https://t.co/kgl8mT98fs
Thank you, @GENbio for covering our new partnership with @Roche and capturing our insights about how the collaboration could overcome several challenges to treating neurological conditions. 👇https://t.co/QaEFereWle